All the news

Bluepharma products arrive to the Brazilian market

12.01.2016 in Bluepharma

Anvisa has inspected Bluepharma’s activity and attested the compliance with Good Manufacturing Practices.

“We will be able to have products in the Brazilian market”, announces the president of Bluepharma, Paulo Barradas Rebelo. This results from the positive evaluation from the Agência Nacional de Vigilância Sanitária (National Health Surveillance Agency) to the company’s activity.

Between November 30th to December 4th, an Anvisa delegation visited Bluepharma’s facilities in São Martinho do Bispo and Taveiro checking the infrastructures, manufacturing conditions and company’s procedures. On the report delivered on January 8th, the inspection certified that the activity of Bluepharma Indústria Farmacêutica, S.A. complies with the Good Manufacturing Practices.

Thus, the company was approved to market its products in Brazil. It is "an emerging market, with growth potential", considers Paulo Barradas Rebelo.

The president of Bluepharma also highlights the strictness that characterizes Anvisa inspections, which reinforces the feeling of satisfaction of the employees by the evaluation result.